BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Proteo Biotech AG 

Am Kiel-Kanal 44

Kiel    D-24106  Germany
Phone: 49-431-8888-462 Fax: 49-431-8888-463


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Proteo Biotech AG (PTEO.OB) Expands Management Board 12/5/2014 9:17:42 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): Final Analysis Of The Phase II Clinical Study On Elafin In Coronary Artery Bypass Surgery Completed 11/21/2014 9:26:36 AM
Proteo Inc. (PTEO.OB) / Proteo Biotech AG (PTEO.OB): Patient Recruitment and Treatment in Elafin CABG Phase II Clinical Trial Completed 11/8/2013 8:09:01 AM
Proteo Inc. (PTEO.OB) /Proteo Biotech AG (PTEO.OB): FDA Grants Orphan Drug Designation to Elafin for Prevention of Inflammatory Complications of Transthoracic Esophagectomy 3/21/2013 11:27:19 AM
Proteo Inc. (PTEO.OB)/ Proteo Biotech AG (PTEO.OB): Proteo's Elafin Will Be Tested at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) 6/18/2010 6:22:05 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): Successful Completion of Patient Recruitment for the Phase II Clinical Trial on Elafin in Patients with Esophagus Cancer 4/23/2010 10:03:28 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): European Medicines Agency European Medicines Evaluation Agency Recommends Orphan Drug Status for Elafin in the Treatment of Esophagus Carcinoma 11/16/2009 10:16:17 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB) - Minapharm/Rhein Minapharm Biogenetics SAE: Approval for a Phase II Clinical Trial with Elafin in Kidney Transplantation 12/10/2008 10:04:58 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB): Start of the Phase II Clinical Trial With Elafin 11/17/2008 11:36:42 AM
Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB) - Minapharm/Rhein Minapharm Biogenetics SAE: Proteo Biotech AG (PTEO.OB), Germany and Minapharm, Egypt Enter into Development and License Agreement for Elafin 8/9/2007 1:28:30 PM
12